Organ Technologies

Organ Technologies is a Japanese biotechnology company that pioneered the field of functional organ regeneration. Founded on the groundbreaking research of Professor Takashi Tsuji, the company focused on developing the "Organ Germ Method," a technology platform designed to bioengineer entire organ units using stem cell populations. Their development pipeline targeted a variety of indications including androgenetic alopecia, tooth loss, and secretory gland dysfunctions such as dry eye and dry mouth. Notably, the company formed a high-profile partnership with Kyocera to advance hair follicle regeneration toward clinical application. Despite achieving significant scientific milestones in tissue engineering, Organ Technologies filed for civil rehabilitation in 2020 and subsequently ceased most business operations. The company's legacy continues to influence the global regenerative medicine landscape and the advancement of organ-level cell therapies.